About Full At Last
Full At Last exists because we believe everyone considering or taking GLP-1 medications deserves access to clear, trustworthy, independent information — not pharmaceutical marketing dressed up as education.
Our Mission
GLP-1 medications are transforming how millions of people manage their weight and metabolic health. But navigating the landscape is overwhelming. Which drug is right for you? What side effects should you expect? How do you eat and exercise while on these medications? What about the new generics?
Most of the information online comes from two sources: pharmaceutical companies trying to sell you their drug, or clinics trying to sell you their service. Both have financial incentives that shape their messaging.
We have no pharmaceutical sponsors. We don't sell prescriptions. We're an independent resource that researches, compares, and explains GLP-1 medications so you can make informed decisions with your healthcare provider.
Who We Are
Full At Last is maintained by an independent editorial team with backgrounds in health research, fitness, and nutrition science. Our content is built through extensive analysis of peer-reviewed clinical studies, FDA data, and real-world patient experiences.
We are not doctors. We don't pretend to be. What we are is a team of researchers and health practitioners who believe that the people considering or taking GLP-1 medications deserve better information than pharmaceutical marketing copy and social media speculation.
Every article goes through a rigorous research process: clinical trial data is reviewed, multiple medical sources are cross-referenced, and content is regularly updated as new evidence emerges. We believe in transparency — we cite our sources, disclose our affiliate relationships, and clearly state that our content is informational, never medical advice.
Our Editorial Standards
Every article on Full At Last follows strict editorial guidelines:
- ✓Evidence-based: We reference peer-reviewed clinical studies, FDA data, and established medical sources. We cite our sources so you can verify our claims.
- ✓Regularly updated: GLP-1 is a fast-moving field. We update our content when new drugs launch, prices change, or new research emerges.
- ✓Independent: No pharmaceutical company pays us or influences our content. Our revenue comes from advertising and affiliate partnerships, which are always clearly disclosed.
- ✓Not medical advice: We're educators, not doctors. We always recommend consulting your healthcare provider before making any medication decisions.
How We Make Money
Transparency matters. Full At Last earns revenue through display advertising and affiliate partnerships. When we recommend a product or service and you make a purchase through our link, we may earn a commission at no extra cost to you. This never influences which products we recommend — our editorial content is completely independent of our advertising relationships.
The Full Signal Newsletter
Weekly insights on GLP-1 medications, nutrition tips, new drug updates, and real stories from real people. Trusted by thousands. Free forever.
No spam. Unsubscribe anytime. We respect your privacy.